References
- 1. Sanyal AJ. Review article: non-alcoholic fatty liver disease and hepatitis C-risk factors and clinical implications. Aliment Pharmacol Ther. 2005; 22(Suppl 2):48-51.10.1111/j.1365-2036.2005.02596.x
- 2. Marra F, Aleffi S, Bertolani C, Petrai I, Vizzutti F. Review article: the pathogenesis of fibrosis in nonalcoholic steatohepatitis. Aliment Pharmacol Ther. 2005; 22(Suppl 2):44-7.10.1111/j.1365-2036.2005.02595.x
- 3. Trombetta M, Spiazzi G, Zoppini G, Muggeo M. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther. 2005; 22(Suppl 2):24-7.
- 4. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology. 2004; 126:586-97.10.1053/j.gastro.2003.11.020
- 5. Clouston AD, Jonsson JR, Powell EE. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis. 2007; 11:173-89.10.1016/j.cld.2007.02.007
- 6. Yokoyama H, Hirose H, Ohgo H, Saito I. Inverse association between serum adiponectin level and transaminase activities in Japanese male workers. J Hepatol. 2004; 41:19-24.10.1016/j.jhep.2004.03.003
- 7. Antunez I, Aponte N, Fernandez-Carbia A, Rodriguez-Perez F, Toro DH. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C. P R Health Sci J. 2004; 23:57-60.
- 8. Myers RP, Messous D, Poynard T, Imbert-Bismut F. Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C. Can J Gastroenterol. 2007; 21:289-94.10.1155/2007/876076
- 9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94:2467-74.10.1111/j.1572-0241.1999.01377.x
- 10. Hu KQ, Kyulo NL, Esrailian E, Thompson K, Chase R, Hillebrand DJ, Runyon BA. Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol. 2004; 40:147-54.10.1016/S0168-8278(03)00479-3
- 11. Adinolfi LE, Durante-Mangoni E, Zampino R, Ruggiero G. Review article: hepatitis C virus-associated steatosis-pathogenic mechanisms and clinical implications. Aliment Pharmacol Ther. 2005; 22(Suppl 2):52-5.
- 12. Harrison SA. Steatosis and chronic hepatitis C infection: mechanisms and significance. Clin Gastroenterol Hepatol. 2005; 3:S92-6.10.1016/S1542-3565(05)00706-8
- 13. Guidi M, Muratori P, Granito A, Muratori L, Lenzi M, Bianchi FB. Steatosis in chronic hepatitis C. Gut. 2006; 55:1047-8.
- 14. Matos CA, Perez RM, Pacheco MS, Figueiredo-Mendes CG, Lopes-Neto E, Oliveira EB, et al. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors. J Gastroenterol Hepatol. 2006; 21:1236-9.10.1111/j.1440-1746.2006.04308.x
- 15. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut. 2006; 55:123-30.10.1136/gut.2005.069757
- 16. Szanto P, Grigorescu M, Dumitru I, Serban A. Steatosis in hepatitis C virus infection. Response to anti-viral therapy. J Gastrointestin Liver Dis. 2006; 15:117-24.
- 17. Zein NN, Poterucha JJ. Steatosis in hepatitis C: the missing link to metabolic abnormalities? Am J Gastroenterol. 2006; 101:2616-8.10.1111/j.1572-0241.2006.00909.x
- 18. Asselah T, Boyer N, Guimont MC, Cazals-Hatem D, Tubach F, Nahon K, et al. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut. 2003; 52:1638-43.10.1136/gut.52.11.1638
- 19. Testino G, Sumberaz A. Liver steatosis and antiviral therapy in chronic hepatitis C. Liver Int. 2007; 27:287.10.1111/j.1478-3231.2006.01417.x
- 20. Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol. 2003; 98:2064-71.10.1111/j.1572-0241.2003.07640.x
- 21. Gordon A, McLean CA, Pedersen JS, Bailey MJ, Roberts SK. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol. 2005; 43:38-44.10.1016/j.jhep.2005.01.031
- 22. Romero-Gomez M. Hepatitis C and insulin resistance: steatosis, fibrosis and non-response. Rev Esp Enferm Dig. 2006; 98:605-15.
- 23. Ramesh S, Sanyal AJ. Hepatitis C and nonalcoholic fatty liver disease. Semin Liver Dis. 2004; 24:399-413.10.1055/s-2004-860869
- 24. Bjornsson E, Angulo P. Hepatitis C and steatosis. Arch Med Res. 2007; 38:621-7.10.1016/j.arcmed.2006.09.001
- 25. Lonardo A, Loria P, Adinolfi LE, Carulli N, Ruggiero G. Hepatitis C and steatosis: a reappraisal. J Viral Hepat. 2006; 13:73-80.10.1111/j.1365-2893.2005.00669.x
- 26. Koike K. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH. Hepatol Res. 2005; 33:145-50.10.1016/j.hepres.2005.09.023
- 27. Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. JHepatol. 2007; 47:598-607.10.1016/j.jhep.2007.07.006
- 28. Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, et al. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-á in chronic hepatitis C patients. Aliment Pharmacol Ther. 2006; 24:1349-57.10.1111/j.1365-2036.2006.03114.x
- 29. Hu KQ, Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, et al. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci. 2007; 52:570-8.10.1007/s10620-006-9418-4
- 30. Sayed HA, El Ayyat A, El Dusoki H, Zoheiry M, Mohamed S, Hassan M, et al. A cross sectional study of hepatitis B, C, some trace elements, heavy metals, aflatoxin B1 and schistosomiasis in a rural population, Egypt. J Egypt Public Health Assoc. 2005; 80:355-88.
- 31. Bedossa P, Moucari R, Chelbi E, Asselah T, Paradis V, Vidaud M, et al. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. Hepatology. 2007; 46:380-7.10.1002/hep.21711
- 32. Oben JA, Paulon E. Fatty liver in chronic hepatitis C infection: unravelling the mechanisms. Gut. 2007; 56:1186-8.10.1136/gut.2006.118422
- 33. Anty R, Gelsi E, Giudicelli J, Marine-Barjoan E, Gual P, Benzaken S, et al. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses. Eur J Gastroenterol Hepatol. 2007; 19:671-7.